Suppr超能文献

脂质体制霉菌素对中性粒细胞减少小鼠播散性烟曲霉感染的活性。

Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.

作者信息

Wallace T L, Paetznick V, Cossum P A, Lopez-Berestein G, Rex J H, Anaissie E

机构信息

Aronex Pharmaceuticals, Inc., The Woodlands, Texas 77381, USA.

出版信息

Antimicrob Agents Chemother. 1997 Oct;41(10):2238-43. doi: 10.1128/AAC.41.10.2238.

Abstract

The purpose of this study was to examine the activity of liposomal nystatin against a disseminated Aspergillus fumigatus infection in neutropenic mice. Mice were made neutropenic with 5-fluorouracil and were administered the antifungal drug intravenously for 5 consecutive days beginning 24 h following infection. Liposomal nystatin, at doses as low as 2 mg/kg of body weight/day, protected neutropenic mice against Aspergillus-induced death in a statistically significant manner at the 50-day time point compared to either the no-treatment, the saline, or the empty-liposome group. This protection was approximately the same as that for free nystatin, a positive control. Histopathological results showed that liposomal nystatin cleared the lungs, spleen, pancreas, kidney, and liver of Aspergillus and that there was no organ damage at the day 5 time point, which was after only three doses of liposomal nystatin. Based on these results in mice, it is probable that liposomal nystatin will be effective against Aspergillus infection in humans.

摘要

本研究的目的是检测脂质体制霉菌素对中性粒细胞减少小鼠播散性烟曲霉感染的活性。用5-氟尿嘧啶使小鼠中性粒细胞减少,并在感染后24小时开始连续5天静脉给予抗真菌药物。与未治疗组、生理盐水组或空脂质体组相比,脂质体制霉菌素以低至2mg/kg体重/天的剂量,在50天时间点以统计学显著方式保护中性粒细胞减少小鼠免受曲霉诱导的死亡。这种保护作用与阳性对照游离制霉菌素大致相同。组织病理学结果显示,脂质体制霉菌素清除了肺、脾、胰腺、肾和肝脏中的曲霉,并且在仅给予三剂脂质体制霉菌素后的第5天时间点没有器官损伤。基于小鼠的这些结果,脂质体制霉菌素很可能对人类曲霉感染有效。

相似文献

1
Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.
Antimicrob Agents Chemother. 1997 Oct;41(10):2238-43. doi: 10.1128/AAC.41.10.2238.
4
Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.
Antimicrob Agents Chemother. 2004 Dec;48(12):4808-12. doi: 10.1128/AAC.48.12.4808-4812.2004.
10
and Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatus.
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.02673-18. Print 2019 Jun.

引用本文的文献

1
pharmacodynamic evaluation of the novel nystatin derivative BSG005 in the invasive candidiasis and invasive pulmonary aspergillosis mouse models.
Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0123424. doi: 10.1128/aac.01234-24. Epub 2024 Oct 29.
2
Efficacy of Liposomal Nystatin in a Rabbit Model of Cryptococcal Meningitis.
J Fungi (Basel). 2024 Jul 26;10(8):520. doi: 10.3390/jof10080520.
3
Fungal Genomics in Respiratory Medicine: What, How and When?
Mycopathologia. 2021 Oct;186(5):589-608. doi: 10.1007/s11046-021-00573-x. Epub 2021 Sep 7.
4
Rodent Models of Invasive Aspergillosis due to : Still a Long Path toward Standardization.
Front Microbiol. 2017 May 16;8:841. doi: 10.3389/fmicb.2017.00841. eCollection 2017.
5
In vivo efficacy of a synthetic coumarin derivative in a murine model of aspergillosis.
PLoS One. 2014 Aug 20;9(8):e103039. doi: 10.1371/journal.pone.0103039. eCollection 2014.
6
[Anti-fungal drugs. Current status and guidelines for their administration].
Clin Transl Oncol. 2005 Oct;7(9):377-88. doi: 10.1007/BF02716583.
7
Efficacy of 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrole-2-yl)-1-methylethyl pentanoate in a murine model of invasive aspergillosis.
Antimicrob Agents Chemother. 2005 Oct;49(10):4365-7. doi: 10.1128/AAC.49.10.4365-4367.2005.
10
In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum.
Antimicrob Agents Chemother. 2002 May;46(5):1388-93. doi: 10.1128/AAC.46.5.1388-1393.2002.

本文引用的文献

1
Fungicidin, an antibiotic produced by a soil actinomycete.
Proc Soc Exp Biol Med. 1951 Jan;76(1):93-7. doi: 10.3181/00379727-76-18397.
2
Nystatin (mycostatin) therapy in experimental coccidioidomycosis.
Am Rev Tuberc. 1955 Jul;72(1):64-70. doi: 10.1164/artpd.1955.72.1.64.
3
Systemic moniliasis treated with mycostatin; case report.
J Invest Dermatol. 1955 Apr;24(4):375. doi: 10.1038/jid.1955.51.
4
DEVELOPMENT OF RESISTANCE TO POLYENE ANTIBIOTICS IN CANDIDA ALBICANS.
J Bacteriol. 1965 Jun;89(6):1533-9. doi: 10.1128/jb.89.6.1533-1539.1965.
5
COMPARATIVE RESPONSES OF MAMMALIAN ERYTHROCYTES AND MICROBIAL PROTOPLASTS TO POLYENE ANTIBIOTICS AND VITAMIN A.
Arch Biochem Biophys. 1963 Aug;102:180-8. doi: 10.1016/0003-9861(63)90169-3.
6
A case of aspergillosis treated with nystatin.
Br Med J. 1959 Feb 7;1(5118):345-6. doi: 10.1136/bmj.1.5118.345.
7
Treatment of the deep mycoses.
AMA Arch Intern Med. 1958 Apr;101(4):765-802. doi: 10.1001/archinte.1958.00260160089013.
8
Experiences with the therapy of sixty cases of deep mycotic infections.
Dis Chest. 1957 Dec;32(6):597-614. doi: 10.1378/chest.32.6.597.
9
Treatment of oral histoplasmosis by local injection with nystatin.
J Am Med Assoc. 1957 Sep 28;165(4):346-8. doi: 10.1001/jama.1957.72980220003009a.
10
Nystatin (mycostatin) in the treatment of monilial and nonmonilial vaginitis.
J Am Med Assoc. 1956 Sep 22;162(4):268-71. doi: 10.1001/jama.1956.02970210008004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验